< %=imgalt%>
Home / Technology News / 2008 / February 2008 / February 12, 2008
Scientists identify key protein target for pneumonia treatment

Technology News

Indonesia hopes to become Indian Ocean tsunami-warning provider by 2011
Indonesia has launched its Tsunami Early Warning System (InaTEWS), with which it hopes to become the Indian Ocean tsunami-warning provider by 2011. ANI

Giant particle smasher to restart in July 2009
An internal report sent to physicists working on the Large Hadron Collider (LHC) at the CERN laboratory near Geneva in Switzerland, has instructed them to restart the giant machine by end of July 2009. ANI

Coming soon, empathetic virtual humans
A completely different breed of virtual humans is being developed by French researchers which will be capable of reading and adapting to our emotions. ANI

Scientists identify key protein target for pneumonia treatment

A team of researchers at Childrens Hospital of Pittsburgh have discovered a protein, known as interleukin 22 (IL-22) that may play a critical role in the development of new therapies to treat pneumonia in children.

London, Feb 12 : A team of researchers at Children's Hospital of Pittsburgh have discovered a protein, known as interleukin 22 (IL-22) that may play a critical role in the development of new therapies to treat pneumonia in children.

The study led by Dr Jay K. Kolls, chief of the Division of Pediatric Pulmonary Medicine, Allergy and Immunology at Children's was conducted using a mice model and could successfully treat the mice with pneumonia by using purified IL-22.

"Currently there is no vaccine that covers all kinds of pneumonia and antibiotic treatment is sometimes limited by antibiotic resistance," Nature quoted Dr. Kolls, as saying.

"As acute respiratory infections are the no. 1 killer of children in the world, progress in the development of novel vaccines or new, more effective treatments is critical," he added.

IL-22 is generated by a lineage of cells known as T Helper Type 17 (Th17) that defends the host against the infections.

"Our results raise the possibility of developing new protein-based therapies using IL-22 to limit or prevent pneumonia," said he said.

The findings appear in the February online issue of Nature Medicine.

ANI

December 5, 2008

December 4, 2008

December 3, 2008

December 2, 2008

December 1, 2008

November 30, 2008